Global and United States Alzheimer's Disease Treatments Market Report & Forecast 2024-2031

Report ID: 1825528 | Published Date: Jan 2025 | No. of Page: 89 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Alzheimer's Disease Treatments Revenue in Alzheimer's Disease Treatments Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Alzheimer's Disease Treatments Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Alzheimer's Disease Treatments Market Size for the Year 2017-2028
        1.2.2 Global Alzheimer's Disease Treatments Market Size for the Year 2017-2028
    1.3 Alzheimer's Disease Treatments Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Alzheimer's Disease Treatments in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Alzheimer's Disease Treatments Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Alzheimer's Disease Treatments Market Dynamics
        1.4.1 Alzheimer's Disease Treatments Industry Trends
        1.4.2 Alzheimer's Disease Treatments Market Drivers
        1.4.3 Alzheimer's Disease Treatments Market Challenges
        1.4.4 Alzheimer's Disease Treatments Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Alzheimer's Disease Treatments by Type
    2.1 Alzheimer's Disease Treatments Market Segment by Type
        2.1.1 Cholinesterase Inhibitors
        2.1.2 NMDA Antagonists
    2.2 Global Alzheimer's Disease Treatments Market Size by Type (2017, 2022 & 2028)
    2.3 Global Alzheimer's Disease Treatments Market Size by Type (2017-2028)
    2.4 United States Alzheimer's Disease Treatments Market Size by Type (2017, 2022 & 2028)
    2.5 United States Alzheimer's Disease Treatments Market Size by Type (2017-2028)
3 Alzheimer's Disease Treatments by Application
    3.1 Alzheimer's Disease Treatments Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Diagnostic Laboratories
        3.1.3 Research and Academic Laboratories
        3.1.4 Others
    3.2 Global Alzheimer's Disease Treatments Market Size by Application (2017, 2022 & 2028)
    3.3 Global Alzheimer's Disease Treatments Market Size by Application (2017-2028)
    3.4 United States Alzheimer's Disease Treatments Market Size by Application (2017, 2022 & 2028)
    3.5 United States Alzheimer's Disease Treatments Market Size by Application (2017-2028)
4 Global Alzheimer's Disease Treatments Competitor Landscape by Company
    4.1 Global Alzheimer's Disease Treatments Market Size by Company
        4.1.1 Top Global Alzheimer's Disease Treatments Companies Ranked by Revenue (2021)
        4.1.2 Global Alzheimer's Disease Treatments Revenue by Player (2017-2022)
    4.2 Global Alzheimer's Disease Treatments Concentration Ratio (CR)
        4.2.1 Alzheimer's Disease Treatments Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Alzheimer's Disease Treatments in 2021
        4.2.3 Global Alzheimer's Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Alzheimer's Disease Treatments Headquarters, Revenue in Alzheimer's Disease Treatments Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Alzheimer's Disease Treatments Headquarters and Area Served
        4.3.2 Global Alzheimer's Disease Treatments Companies Revenue in Alzheimer's Disease Treatments Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Alzheimer's Disease Treatments Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Alzheimer's Disease Treatments Market Size by Company
        4.5.1 Top Alzheimer's Disease Treatments Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Alzheimer's Disease Treatments Revenue by Players (2020, 2021 & 2022)
5 Global Alzheimer's Disease Treatments Market Size by Region
    5.1 Global Alzheimer's Disease Treatments Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Alzheimer's Disease Treatments Market Size by Region (2017-2028)
        5.2.1 Global Alzheimer's Disease Treatments Market Size by Region: 2017-2022
        5.2.2 Global Alzheimer's Disease Treatments Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Alzheimer's Disease Treatments Market Size YoY Growth 2017-2028
        6.1.2 North America Alzheimer's Disease Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Alzheimer's Disease Treatments Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Alzheimer's Disease Treatments Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Alzheimer's Disease Treatments Market Size YoY Growth 2017-2028
        6.3.2 Europe Alzheimer's Disease Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Alzheimer's Disease Treatments Market Size YoY Growth 2017-2028
        6.4.2 Latin America Alzheimer's Disease Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Alzheimer's Disease Treatments Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Alzheimer's Disease Treatments Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Eisai
        7.1.1 Eisai Company Details
        7.1.2 Eisai Business Overview
        7.1.3 Eisai Alzheimer's Disease Treatments Introduction
        7.1.4 Eisai Revenue in Alzheimer's Disease Treatments Business (2017-2022)
        7.1.5 Eisai Recent Development
    7.2 Forest Laboratories
        7.2.1 Forest Laboratories Company Details
        7.2.2 Forest Laboratories Business Overview
        7.2.3 Forest Laboratories Alzheimer's Disease Treatments Introduction
        7.2.4 Forest Laboratories Revenue in Alzheimer's Disease Treatments Business (2017-2022)
        7.2.5 Forest Laboratories Recent Development
    7.3 H. Lundbeck
        7.3.1 H. Lundbeck Company Details
        7.3.2 H. Lundbeck Business Overview
        7.3.3 H. Lundbeck Alzheimer's Disease Treatments Introduction
        7.3.4 H. Lundbeck Revenue in Alzheimer's Disease Treatments Business (2017-2022)
        7.3.5 H. Lundbeck Recent Development
    7.4 Johnson and Johnson
        7.4.1 Johnson and Johnson Company Details
        7.4.2 Johnson and Johnson Business Overview
        7.4.3 Johnson and Johnson Alzheimer's Disease Treatments Introduction
        7.4.4 Johnson and Johnson Revenue in Alzheimer's Disease Treatments Business (2017-2022)
        7.4.5 Johnson and Johnson Recent Development
    7.5 Merz Pharma
        7.5.1 Merz Pharma Company Details
        7.5.2 Merz Pharma Business Overview
        7.5.3 Merz Pharma Alzheimer's Disease Treatments Introduction
        7.5.4 Merz Pharma Revenue in Alzheimer's Disease Treatments Business (2017-2022)
        7.5.5 Merz Pharma Recent Development
    7.6 Novartis
        7.6.1 Novartis Company Details
        7.6.2 Novartis Business Overview
        7.6.3 Novartis Alzheimer's Disease Treatments Introduction
        7.6.4 Novartis Revenue in Alzheimer's Disease Treatments Business (2017-2022)
        7.6.5 Novartis Recent Development
    7.7 Pfizer
        7.7.1 Pfizer Company Details
        7.7.2 Pfizer Business Overview
        7.7.3 Pfizer Alzheimer's Disease Treatments Introduction
        7.7.4 Pfizer Revenue in Alzheimer's Disease Treatments Business (2017-2022)
        7.7.5 Pfizer Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Alzheimer's Disease Treatments Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Alzheimer's Disease Treatments Market Trends
    Table 3. Alzheimer's Disease Treatments Market Drivers
    Table 4. Alzheimer's Disease Treatments Market Challenges
    Table 5. Alzheimer's Disease Treatments Market Restraints
    Table 6. Global Alzheimer's Disease Treatments Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Alzheimer's Disease Treatments Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Alzheimer's Disease Treatments Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Alzheimer's Disease Treatments Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Alzheimer's Disease Treatments Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Alzheimer's Disease Treatments Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Alzheimer's Disease Treatments Revenue Share by Player, 2017-2022
    Table 13. Global Alzheimer's Disease Treatments Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Alzheimer's Disease Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Treatments as of 2021)
    Table 15. Top Players of Alzheimer's Disease Treatments in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Alzheimer's Disease Treatments Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Alzheimer's Disease Treatments Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Alzheimer's Disease Treatments Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Alzheimer's Disease Treatments Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Alzheimer's Disease Treatments Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Alzheimer's Disease Treatments Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Alzheimer's Disease Treatments Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Alzheimer's Disease Treatments Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Alzheimer's Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Alzheimer's Disease Treatments Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Alzheimer's Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Alzheimer's Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Alzheimer's Disease Treatments Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Eisai Company Details
    Table 31. Eisai Business Overview
    Table 32. Eisai Alzheimer's Disease Treatments Product
    Table 33. Eisai Revenue in Alzheimer's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 34. Eisai Recent Development
    Table 35. Forest Laboratories Company Details
    Table 36. Forest Laboratories Business Overview
    Table 37. Forest Laboratories Alzheimer's Disease Treatments Product
    Table 38. Forest Laboratories Revenue in Alzheimer's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 39. Forest Laboratories Recent Development
    Table 40. H. Lundbeck Company Details
    Table 41. H. Lundbeck Business Overview
    Table 42. H. Lundbeck Alzheimer's Disease Treatments Product
    Table 43. H. Lundbeck Revenue in Alzheimer's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 44. H. Lundbeck Recent Development
    Table 45. Johnson and Johnson Company Details
    Table 46. Johnson and Johnson Business Overview
    Table 47. Johnson and Johnson Alzheimer's Disease Treatments Product
    Table 48. Johnson and Johnson Revenue in Alzheimer's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 49. Johnson and Johnson Recent Development
    Table 50. Merz Pharma Company Details
    Table 51. Merz Pharma Business Overview
    Table 52. Merz Pharma Alzheimer's Disease Treatments Product
    Table 53. Merz Pharma Revenue in Alzheimer's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 54. Merz Pharma Recent Development
    Table 55. Novartis Company Details
    Table 56. Novartis Business Overview
    Table 57. Novartis Alzheimer's Disease Treatments Product
    Table 58. Novartis Revenue in Alzheimer's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 59. Novartis Recent Development
    Table 60. Pfizer Company Details
    Table 61. Pfizer Business Overview
    Table 62. Pfizer Alzheimer's Disease Treatments Product
    Table 63. Pfizer Revenue in Alzheimer's Disease Treatments Business (2017-2022) & (US$ Million)
    Table 64. Pfizer Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Alzheimer's Disease Treatments Product Picture
    Figure 2. Global Alzheimer's Disease Treatments Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Alzheimer's Disease Treatments Market Size 2017-2028 (US$ Million)
    Figure 4. United States Alzheimer's Disease Treatments Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Alzheimer's Disease Treatments Market Size 2017-2028 (US$ Million)
    Figure 6. United States Alzheimer's Disease Treatments Market Share in Global 2017-2028
    Figure 7. Alzheimer's Disease Treatments Report Years Considered
    Figure 8. Product Picture of Cholinesterase Inhibitors
    Figure 9. Product Picture of NMDA Antagonists
    Figure 10. Global Alzheimer's Disease Treatments Market Share by Type in 2022 & 2028
    Figure 11. Global Alzheimer's Disease Treatments Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Alzheimer's Disease Treatments Market Share by Type (2017-2028)
    Figure 13. United States Alzheimer's Disease Treatments Market Share by Type in 2022 & 2028
    Figure 14. United States Alzheimer's Disease Treatments Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Alzheimer's Disease Treatments Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Diagnostic Laboratories
    Figure 18. Product Picture of Research and Academic Laboratories
    Figure 19. Product Picture of Others
    Figure 20. Global Alzheimer's Disease Treatments Market Share by Application in 2022 & 2028
    Figure 21. Global Alzheimer's Disease Treatments Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Alzheimer's Disease Treatments Market Share by Application (2017-2028)
    Figure 23. United States Alzheimer's Disease Treatments Market Share by Application in 2022 & 2028
    Figure 24. United States Alzheimer's Disease Treatments Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Alzheimer's Disease Treatments Market Share by Application (2017-2028)
    Figure 26. North America Alzheimer's Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Alzheimer's Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Alzheimer's Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Alzheimer's Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Alzheimer's Disease Treatments Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.A.E Alzheimer's Disease Treatments Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Eisai Revenue Growth Rate in Alzheimer's Disease Treatments Business (2017-2022)
    Figure 55. Forest Laboratories Revenue Growth Rate in Alzheimer's Disease Treatments Business (2017-2022)
    Figure 56. H. Lundbeck Revenue Growth Rate in Alzheimer's Disease Treatments Business (2017-2022)
    Figure 57. Johnson and Johnson Revenue Growth Rate in Alzheimer's Disease Treatments Business (2017-2022)
    Figure 58. Merz Pharma Revenue Growth Rate in Alzheimer's Disease Treatments Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Alzheimer's Disease Treatments Business (2017-2022)
    Figure 60. Pfizer Revenue Growth Rate in Alzheimer's Disease Treatments Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eisai
Forest Laboratories
H. Lundbeck
Johnson and Johnson
Merz Pharma
Novartis
Pfizer
Frequently Asked Questions
Alzheimer's Disease Treatments report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alzheimer's Disease Treatments report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alzheimer's Disease Treatments report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports